Prevail Therapeutics develops gene therapies for Parkinson's disease and other neurodegenerative disorders. Their mission is to create medicines that slow or stop the neurodegenerative process by targeting the root genetic causes. They use a precision medicine approach to target patient populations with urgent unmet needs.